BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Schönauer R, Sierks D, Boerrigter M, et al. (2023) Sex, genotype, and liver volume progression as risk of hospitalization determinants in autosomal dominant polycystic liver disease. Gastroenterology |
| Boerrigter MM, Duijzer R, Te Morsche RHM, et al. (2023) Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease. Genes. 14 |
| Barten TRM, Atsma F, van der Meer AJ, et al. (2023) Higher need for polycystic liver disease therapy in female patients: sex-specific association between liver volume and need for therapy. Hepatology (Baltimore, Md.) |
| Waddell SH, Yao Y, Olaizola P, et al. (2023) A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease. Science Translational Medicine. 15: eabq5930 |
| Boerrigter MM, Te Morsche RHM, Venselaar H, et al. (2023) Novel α-1,3-Glucosyltransferase Variants and Their Broad Clinical Polycystic Liver Disease Spectrum. Genes. 14 |
| Zachou K, Azariadis K, Lytvyak E, et al. (2023) Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease. Jhep Reports : Innovation in Hepatology. 5: 100778 |
| Olaizola P, Rodrigues PM, Caballero-Camino FJ, et al. (2022) Genetics, pathobiology and therapeutic opportunities of polycystic liver disease. Nature Reviews. Gastroenterology & Hepatology |
| van Son KC, Tushuizen ME, Holleboom AG, et al. (2022) A non-invasive score for nonalcoholic fatty liver disease (NAFLD) cirrhosis. European Journal of Internal Medicine. 98: 43-44 |
| Larsen LE, van den Boogert MAW, Rios-Ocampo WA, et al. (2021) Defective lipid droplet - lysosome interaction causes fatty liver disease as evidenced by human mutations in TMEM199 and CCDC115. Cellular and Molecular Gastroenterology and Hepatology |
| Aapkes SE, Bernts LHP, van den Berg M, et al. (2021) Tamoxifen for the treatment of polycystic liver disease: A case report. Medicine. 100: e26797 |